L. Martin

Survival comparison of radiosurgery-eligible and -ineligible malignant glioma patients treated with hyperfractionated radiation therapy and carmustine: a report of Radiation Therapy Oncology Group 83-02.

W. Curran, T. Phillips, J. Schwade, 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

interruptions adversely affect local control and survival with hyperfractionated radiation therapy of carcinomas of the upper respiratory and digestive tracts new evidence for accelerated proliferation from radiation therapy oncology group protocol 8313

P. Rubin, T. Pajak, K. Fu, 1992, Cancer.

Radiation Therapy Oncology Group: radiosurgery quality assurance guidelines.

L Souhami, M Gillin, E. Shaw, 1993, International journal of radiation oncology, biology, physics.

White matter changes are correlated significantly with radiation dose. Observations from a randomized dose‐escalation trial for malignant glioma (radiation therapy oncology group 83‐02)

D. Nelson, W. Curran, D. Yousem, 1994, Cancer.

Hyperfractionated Radiation Therapy of Carcinomas of the Upper Respiratory and Digestive Tracts

K., L. Coia, M. Mohiuddin, 2006 .